Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis

Summary

This pilot study evaluates the safety and feasibility of losartan in pediatric patients with pulmonary vein stenosis. It is an open label single arm interventional study. The patient population involves pediatric patients with stenosis in 2 or more pulmonary veins. Patients will be given losartan for 1 year. Outcomes include measures of safety/adverse events and progression of pulmonary vein stenosis.

Timeline

Start

2016-05

Primary completion

2021-05

Completion

2021-05

Drugs

Indications